Literature DB >> 10928298

Nitric oxide--angiotensin II axis in renal and cardiovascular injury.

A Adam1, L Raij.   

Abstract

The knowledge and the information about Renin Angiotensin System and Arginine-Nitric Oxide pathway helped us in understanding more about cardiac, vascular and renal systems, their function, the physiology, and pathophysiology of different diseases that may affect them. The existence of a Nitric Oxide/Angiotensin II axis, brought modification to our ways of thinking with new and more pathophysiological approaches to the treatment of hypertension and end-organ disease. There appears to be a link between hypertension, salt sensitivity, endothelial function and NO-AnglI axis on one side and end organ damage on the other side. Anti-hypertensive agents that can restore endothelial function beside their antihypertensive effect, may be better in preventing or at least slowing end-organ damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928298

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

1.  Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Authors:  Aaron J Polichnowski; Limin Lu; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

Review 2.  Statins and proteinuria.

Authors:  Donald G Vidt
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

3.  Protective effect of Urtica dioica L. on renal ischemia/reperfusion injury in rat.

Authors:  Mustafa Burak Sayhan; Mehmet Kanter; Serhat Oguz; Mustafa Erboga
Journal:  J Mol Histol       Date:  2012-07-04       Impact factor: 2.611

Review 4.  Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases.

Authors:  Norman K Hollenberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

5.  CD4(+)CD25(+) T Cells in primary malignant hypertension related kidney injury.

Authors:  Hongdong Huang; Yang Luo; Yumei Liang; Xidai Long; Youming Peng; Zhihua Liu; Xiaojun Wen; Meng Jia; Ru Tian; Chengli Bai; Cui Li; Fuliang He; Qiushi Lin; Xueyan Wang; Xiaoqun Dong
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.